Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
EnerSys
ENS
$7.42B
| $697K | ﹤0.01% |
6,900
-46,216
| -87% | -$4.25M |
|
2602
iShare MSCI Eurozone ETF
EZU
$9.97B
| $697K | ﹤0.01% |
+14,700
| New | +$647K |
|
2603
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.77B
| $695K | ﹤0.01% |
4,400
-1,600
| -27% | -$230K |
|
2604
ClearOne Inc
CLRO
$14M
| $694K | ﹤0.01% |
42,764
-7,983
| -16% | -$90.9K |
|
2605
Factset
FDS
$10.1B
| $692K | ﹤0.01% |
+1,450
| New | +$653K |
|
2606
Good Times Restaurants
GTIM
$16.4M
| $691K | ﹤0.01% |
271,878
-19,405
| -7% | -$50.8K |
|
2607
Identive
INVE
$64.1M
| $691K | ﹤0.01% |
83,882
-53,600
| -39% | -$378K |
|
|
ACOR
2608
DELISTED
Acorda Therapeutics
ACOR
| $691K | ﹤0.01% |
45,761
-300
| -0.7% | -$3.4K |
|
|
SRTA
2609
Strata Critical Medical Inc
SRTA
$522M
| $690K | ﹤0.01% |
195,400
-194,799
| -50% | -$559K |
|
2610
Direxion Daily Regional Banks Bull 3X ETF
DPST
$417M
| $690K | ﹤0.01% |
+7,100
| New | +$458K |
|
|
KEEL
2611
Keel Infrastructure Corp
KEEL
$2.17B
| $689K | ﹤0.01% |
236,500
-1,336,500
| -85% | -$2.15M |
|
|
INVX
2612
Innovex International
INVX
$2.18B
| $688K | ﹤0.01% |
+29,559
| New | +$694K |
|
2613
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6.16B
| $687K | ﹤0.01% |
+21,050
| New | +$644K |
|
2614
Landstar System
LSTR
$6.45B
| $686K | ﹤0.01% |
3,540
-94,100
| -96% | -$16.7M |
|
2615
Sensus Healthcare
SRTS
$47.1M
| $686K | ﹤0.01% |
290,748
-41,525
| -12% | -$97.2K |
|
2616
Savers
SVV
$1.64B
| $686K | ﹤0.01% |
39,477
-120,592
| -75% | -$1.82M |
|
|
ALIM
2617
DELISTED
Alimera Sciences
ALIM
| $686K | ﹤0.01% |
158,794
+45,900
| +41% | +$155K |
|
2618
Kaltura
KLTR
$249M
| $684K | ﹤0.01% |
351,000
+12,900
| +4% | +$22.8K |
|
2619
Karat Packaging
KRT
$955M
| $684K | ﹤0.01% |
27,515
+8,900
| +48% | +$196K |
|
|
OGI
2620
Organigram Holdings
OGI
$173M
| $684K | ﹤0.01% |
522,048
+61,100
| +13% | +$75.1K |
|
2621
Oportun Financial
OPRT
$355M
| $682K | ﹤0.01% |
174,500
+71,600
| +70% | +$306K |
|
2622
Edgewell Personal Care
EPC
$1.31B
| $681K | ﹤0.01% |
+18,600
| New | +$658K |
|
2623
Byline Bancorp
BY
$1.78B
| $680K | ﹤0.01% |
28,871
-500
| -2% | -$10.4K |
|
2624
Vanguard Energy ETF
VDE
$10.6B
| $680K | ﹤0.01% |
5,800
-9,600
| -62% | -$1.15M |
|
2625
Pacer Global Cash Cows Dividend ETF
GCOW
$3.49B
| $679K | ﹤0.01% |
+19,800
| New | +$649K |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.